For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, ...

According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

Recent research easing suicidality concerns about GLP-1s and suggesting potential psychiatric benefit has led to a call for ...

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

With weight management being a significant health concern for many, modern medical treatments are offering new solutions to ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.